Cancer chemoprevention is not a failure

Carcinogenesis

Volumn 35, Issue 9, 2014, Pages 2154-2155

  Adhami, Vaqar Mustafa ^a   Bailey, Howard H ^b   Mukhtar, Hasan ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EFLORNITHINE; SULINDAC; TAMOXIFEN;

ADENOMATOUS POLYP; BASAL CELL CARCINOMA; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER PREVENTION; COLORECTAL ADENOMA; DIETARY INTAKE; DRUG TREATMENT FAILURE; FAMILIAL COLON POLYPOSIS; FOLLOW UP; HIGH RISK POPULATION; HUMAN; LETTER; SKIN CANCER;

CHEMOPREVENTION; HUMANS; NEOPLASMS;

EID: 84906830256     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu141     Document Type: Letter

References (25)

1. Potter,J. (2014) The failure of cancer chemoprevention. Carcinogenesis. Epub ahead of print, 11 March 2014.
2. Adhami,V.M. et al. (2013) Human cancer chemoprevention: hurdles and challenges. Top. Curr. Chem., 329, 203-220.
3. Mukhtar,H. (2012) Chemoprevention: making it a success story for controlling human cancer. Cancer Lett., 326, 123-127.
4. Hong,W.K. et al. (1990) Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N. Engl. J. Med., 323, 795-801.
5. Fisher,B. et al. (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. Natl Cancer Inst., 90, 1371-1388.
6. Cuzick,J. et al. (2003) Overview of the main outcomes in breast-cancer prevention trials. Lancet, 361, 296-300.
7. Baron,R.S. et al. (2006) A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. Gastroenterol., 131, 1674-1682.
8. Bertagnolli,M.M. et al. APC Study Investigators. (2006) Celecoxib for the prevention of sporadic colorectal adenomas. N. Engl. J. Med., 355, 873-884.
9. Bailey,H.H. et al. (2010) A randomized, double-blind, placebo-controlled phase 3 skin cancer prevention study of {alpha}-difluoromethylornithine in subjects with previous history of skin cancer. Cancer Prev. Res. (Phila)., 3, 35-47.
10. Meyskens,F.L. Jr et al. (2008) Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebocontrolled, double-blind trial. Cancer Prev. Res. (Phila)., 1, 32-38.
11. Kaplan,S.A. et al. (2009) PCPT: evidence that finasteride reduces risk of most frequently detected intermediate- and high-grade (Gleason score 6 and 7) cancer. Urology, 73, 935-939.
12. Bettuzzi,S. et al. (2006) Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res., 66, 1234-1240.
13. Brausi,M. et al. (2008) Chemoprevention of human prostate cancer by green tea catechins: two years later. A follow-up update. Eur. Urol., 54, 472-473.
14. Paavonen,J. et al. HPV PATRICIA Study Group. (2009) Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet, 374, 301-314.
15. Elmets,C.A. et al. (2010) Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial. J. Natl Cancer Inst., 102, 1835-1844.
16. Wang,L.S. et al. (2014) A phase ib study of the effects of black raspberries on rectal polyps in patients with familial adenomatous polyposis. Cancer Prev. Res. (Phila)., 7, 666-674.
17. Zu,K. et al. (2014) Dietary lycopene, angiogenesis, and prostate cancer: a prospective study in the prostate-specific antigen era. J. Natl Cancer Inst., 106, djt430.
18. Havrilesky,L.J. et al. (2013) Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis. Obstet. Gynecol., 122, 139-147.
19. Guha,M. (2013) The pill and ovarian cancer prevention. J. Natl Cancer Inst., 105, 154-156.
20. Evans,J.M. et al. (2005) Metformin and reduced risk of cancer in diabetic patients. BMJ, 330, 1304-1305.
21. Noto,H. et al. (2012) Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis. PLoS One, 7, e33411.
22. Kim,S.E. (2014) The benefit-risk consideration in long-term use of alternate-day, low dose aspirin: focus on colorectal cancer prevention. Ann. Gastroenterol., 27, 87-88.
23. Gupta,S. et al. (2001) Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc. Natl Acad. Sci. USA., 98, 10350-10355.
24. Adhami,V.M. et al. (2009) Effective prostate cancer chemopreventive intervention with green tea polyphenols in the TRAMP model depends on the stage of the disease. Clin. Cancer Res., 15, 1947-1953.
25. Steward,W.P. et al. (2013) Cancer chemoprevention: a rapidly evolving field. Br. J. Cancer, 109, 1-7.